Arrow Greentech Limited has informed the Exchange regarding 'Presentation On Business Performance June 2025'.
ARROWGREEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Arrow Greentech submitted its Q1 FY26 business performance presentation to the exchanges. Revenue came in at Rs. 416 million, down 27% sequentially and 37% year-on-year, mainly dragged by a 32% QoQ and 45% YoY fall in the Hightech Products segment. However, profitability strengthened on a sequential basis: EBITDA margin expanded to 34.2% from 28.0% in Q4 FY25, and PAT margin rose to 25.1% from 19.3%, a 580 bps jump. Green Products grew 3% QoQ and 80% YoY to Rs. 72 million. Chairman Shilpan Patel attributed margin gains to operational efficiency while flagging softer revenue, near-zero US exports, and a pick-up in green product exports to Brazil. Strategic focus remains on high-tech security products, Atma Nirbhar Bharat-aligned solutions, and the pharma subsidiary Avery Pharmaceuticals, which has signed a long-term export contract with a large MNC.
The sharp revenue decline, especially in the core Hightech Products business, is a concern for shareholders despite better margins. The improved margin profile and green products traction, along with new pharma export contracts, offer some near-term support, but watch for stabilisation in the Hightech segment and execution on the Avery Pharmaceuticals CDMO pipeline.